Genetic Variability in Oxidative Stress, Inflammatory, and Neurodevelopmental Pathways: Impact on the Susceptibility and Course of Spinal Muscular Atrophy

Overview

Journal Cell Mol Neurobiol

Publisher Springer

Specialties Cell Biology
Molecular Biology
Neurology

Date 2024 Oct 28

PMID 39463208

Authors

Marusa Barbo

Blaz Koritnik

Lea Leonardis

Tanja Blagus

Vita Dolzan

Metka Ravnik-Glavac

Affiliations

Soon will be listed here.

Abstract

The spinal muscular atrophy (SMA) phenotype strongly correlates with the SMN2 gene copy number. However, the severity and progression of the disease vary widely even among affected individuals with identical copy numbers. This study aimed to investigate the impact of genetic variability in oxidative stress, inflammatory, and neurodevelopmental pathways on SMA susceptibility and clinical progression. Genotyping for 31 genetic variants across 20 genes was conducted in 54 SMA patients and 163 healthy controls. Our results revealed associations between specific polymorphisms and SMA susceptibility, disease type, age at symptom onset, and motor and respiratory function. Notably, the TNF rs1800629 and BDNF rs6265 polymorphisms demonstrated a protective effect against SMA susceptibility, whereas the IL6 rs1800795 was associated with an increased risk. The polymorphisms CARD8 rs2043211 and BDNF rs6265 were associated with SMA type, while SOD2 rs4880, CAT rs1001179, and MIR146A rs2910164 were associated with age at onset of symptoms after adjustment for clinical parameters. In addition, GPX1 rs1050450 and HMOX1 rs2071747 were associated with motor function scores and lung function scores, while MIR146A rs2910164, NOTCH rs367398 SNPs, and GSTM1 deletion were associated with motor and upper limb function scores, and BDNF rs6265 was associated with lung function scores after adjustment. These findings emphasize the potential of genetic variability in oxidative stress, inflammatory processes, and neurodevelopmental pathways to elucidate the complex course of SMA. Further exploration of these pathways offers a promising avenue for developing personalized therapeutic strategies for SMA patients.

References

Simone C, Ramirez A, Bucchia M, Rinchetti P, Rideout H, Papadimitriou D . Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?. Cell Mol Life Sci. 2015; 73(5):1003-20. PMC: 4756905. DOI: 10.1007/s00018-015-2106-9. View

Ratni H, Ebeling M, Baird J, Bendels S, Bylund J, Chen K . Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA). J Med Chem. 2018; 61(15):6501-6517. DOI: 10.1021/acs.jmedchem.8b00741. View

Ran C, Wirdefeldt K, Brodin L, Ramezani M, Westerlund M, Xiang F . Genetic Variations and mRNA Expression of NRF2 in Parkinson's Disease. Parkinsons Dis. 2017; 2017:4020198. PMC: 5433415. DOI: 10.1155/2017/4020198. View

Garcia-Martin E, Jimenez-Jimenez F, Alonso-Navarro H, Martinez C, Zurdo M, Turpin-Fenoll L . Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Restless Legs Syndrome. Medicine (Baltimore). 2015; 94(34):e1448. PMC: 4602895. DOI: 10.1097/MD.0000000000001448. View

DAmico A, Mercuri E, Tiziano F, Bertini E . Spinal muscular atrophy. Orphanet J Rare Dis. 2011; 6:71. PMC: 3231874. DOI: 10.1186/1750-1172-6-71. View

Deguise M, De Repentigny Y, McFall E, Auclair N, Sad S, Kothary R . Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice. Hum Mol Genet. 2017; 26(4):801-819. PMC: 5409095. DOI: 10.1093/hmg/ddw434. View

Deng C, Chen H . Brain-derived neurotrophic factor/tropomyosin receptor kinase B signaling in spinal muscular atrophy and amyotrophic lateral sclerosis. Neurobiol Dis. 2023; 190:106377. DOI: 10.1016/j.nbd.2023.106377. View

Kashima T, Manley J . A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet. 2003; 34(4):460-3. DOI: 10.1038/ng1207. View

Sahashi K, Ling K, Hua Y, Wilkinson J, Nomakuchi T, Rigo F . Pathological impact of SMN2 mis-splicing in adult SMA mice. EMBO Mol Med. 2013; 5(10):1586-601. PMC: 3799581. DOI: 10.1002/emmm.201302567. View

10.

Zhang B, Wang A, Xia C, Lin Q, Chen C . A single nucleotide polymorphism in primary-microRNA-146a reduces the expression of mature microRNA-146a in patients with Alzheimer's disease and is associated with the pathogenesis of Alzheimer's disease. Mol Med Rep. 2015; 12(3):4037-4042. PMC: 4526084. DOI: 10.3892/mmr.2015.3968. View

11.

Yoon K, Gaiano N . Notch signaling in the mammalian central nervous system: insights from mouse mutants. Nat Neurosci. 2005; 8(6):709-15. DOI: 10.1038/nn1475. View

12.

Tarabal O, Caraballo-Miralles V, Cardona-Rossinyol A, Correa F, Olmos G, Llado J . Mechanisms involved in spinal cord central synapse loss in a mouse model of spinal muscular atrophy. J Neuropathol Exp Neurol. 2014; 73(6):519-35. DOI: 10.1097/NEN.0000000000000074. View

13.

Atanasovska Velkovska M, Goricar K, Blagus T, Dolzan V, Cvenkel B . Association of Genetic Polymorphisms in Oxidative Stress and Inflammation Pathways with Glaucoma Risk and Phenotype. J Clin Med. 2021; 10(5). PMC: 7967191. DOI: 10.3390/jcm10051148. View

14.

Ayuso P, Martinez C, Lorenzo-Betancor O, Pastor P, Luengo A, Jimenez-Jimenez F . A polymorphism located at an ATG transcription start site of the heme oxygenase-2 gene is associated with classical Parkinson's disease. Pharmacogenet Genomics. 2011; 21(9):565-71. DOI: 10.1097/FPC.0b013e328348f729. View

15.

Matsushita S, Arai H, Matsui T, Yuzuriha T, Urakami K, Masaki T . Brain-derived neurotrophic factor gene polymorphisms and Alzheimer's disease. J Neural Transm (Vienna). 2004; 112(5):703-11. DOI: 10.1007/s00702-004-0210-3. View

16.

Mirowska-Guzel D, Gromadzka G, Mach A, Czlonkowski A, Czlonkowska A . Association of IL1A, IL1B, ILRN, IL6, IL10 and TNF-α polymorphisms with risk and clinical course of multiple sclerosis in a Polish population. J Neuroimmunol. 2011; 236(1-2):87-92. DOI: 10.1016/j.jneuroim.2011.04.014. View

17.

Sison S, Patitucci T, Seminary E, Villalon E, Lorson C, Ebert A . Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy. Hum Mol Genet. 2017; 26(17):3409-3420. DOI: 10.1093/hmg/ddx230. View

18.

Escobales N, Nunez R, Javadov S . Mitochondrial angiotensin receptors and cardioprotective pathways. Am J Physiol Heart Circ Physiol. 2019; 316(6):H1426-H1438. PMC: 6620675. DOI: 10.1152/ajpheart.00772.2018. View

19.

Thelen M, Wirth B, Kye M . Mitochondrial defects in the respiratory complex I contribute to impaired translational initiation via ROS and energy homeostasis in SMA motor neurons. Acta Neuropathol Commun. 2020; 8(1):223. PMC: 7754598. DOI: 10.1186/s40478-020-01101-6. View

20.

Baune B, Konrad C, Grotegerd D, Suslow T, Ohrmann P, Bauer J . Tumor necrosis factor gene variation predicts hippocampus volume in healthy individuals. Biol Psychiatry. 2012; 72(8):655-62. DOI: 10.1016/j.biopsych.2012.04.002. View